Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 8Lymphoid 7Gastrointestinal 6Other hematologic neoplasm 5CNS 5Breast 5Gynecologic 4Thoracic 3Sarcoma 2Plasma cell 2Myeloid 2Endocrine 2Dermatologic 2Other solid neoplasm 1NET 1

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 2Toxemia 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Diabetes, Gestational 1Cardiovascular Diseases 1Carcinoma 1Brain Neoplasms 1

Interventions

Paclitaxel 162Fulvestrant 157Trastuzumab 156pembrolizumab 146Letrozole 137Carboplatin 118pertuzumab 104Capecitabine 104Specimen Handling 102Cyclophosphamide 102Anastrozole 90palbociclib 86abemaciclib 82Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 74trastuzumab deruxtecan 68Radiotherapy 62Biopsy 59Surveys and Questionnaires 55Gemcitabine 53130-nm albumin-bound paclitaxel 53olaparib 52sacituzumab govitecan 51Blood Specimen Collection 51Standard of Care 49Taxes 48eribulin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Positron-Emission Tomography × Breast × 1 year × Clear all
NCT05632601 2026-05-08

HER-CROWN

Ottawa Heart Institute Research Corporation

Phase NA Active not recruiting
176 enrolled
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT06586047 2026-03-27

Breast Cancer PSMA PET

University of Iowa

Phase EARLY_PHASE1 Recruiting
30 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00367666 2026-03-10

Using Diagnostic Tools to Stage Breast Cancer

University of Pennsylvania

Phase NA Active not recruiting
400 enrolled
Breast

Breast Neoplasms

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

City of Hope Medical Center

Phase 4 Recruiting
10 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
36 enrolled 7 charts
Breast

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡